Cellectricon, Censo Biotechnologies launch joint technology access program to accelerate CNS and pain research - News-Medical.net

News-Medical.net
Cellectricon, Censo Biotechnologies launch joint technology access program to accelerate CNS and pain research
News-Medical.net
Cellectricon AB and Censo Biotechnologies Ltdare announcing the introduction of a joint technology access program for a fully humanized phenotypic screening platform targeting preclinical neuroscience and chronic pain research. The approach ...